Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2017-01-31

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.2174/1389557516666161013104554PMID 27739361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Polyplexes as Combinatory Drug Carriers of Doxorubicin and Cisplatin: An in Vitro Study.

  2015cited by this paper
• Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies

  2015cited by this paper
• Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates.

  2015cited by this paper
• UPR, autophagy, and mitochondria crosstalk underlies the ER stress response.

  2015cited by this paper
• Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

  2015cited by this paper
• Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.

  2015cited by this paper
• Targeting mitochondria metabolism for cancer therapy.

  2015cited by this paper
• The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.

  2015cited by this paper
• Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.

  2015cited by this paper
• A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.

  2015cited by this paper
• Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.

  2015cited by this paper
• Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells

  2015cited by this paper
• Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.

  2014cited by this paper
• Stimuli-sensitive nanopreparations for combination cancer therapy.

  2014cited by this paper
• Engineered nanoparticles interacting with cells: size matters

  2014cited by this paper
• Nanopreparations for organelle-specific delivery in cancer.

  2014cited by this paper
• Cancer therapy: Targeting mitochondria and other sub-cellular organelles.

  2014cited by this paper
• Lysosome: the cell's 'suicidal bag' as a promising cancer target.

  2014cited by this paper
• Insight into nanoparticle cellular uptake and intracellular targeting.

  2014cited by this paper
• Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.

  2014cited by this paper
• Aluminum–phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy

  2014cited by this paper
• Subcellular drug targeting, pharmacokinetics and bioavailability

  2014cited by this paper
• Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.

  2014cited by this paper
• Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance

  2014cited by this paper
• Signals from the lysosome: a control centre for cellular clearance and energy metabolism

  2013cited by this paper
• Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields.

  2013cited by this paper
• Immunogenic cell death in cancer therapy.

  2013cited by this paper
• Targeted delivery of doxorubicin to mitochondria.

  2013cited by this paper
• Crosstalk between ER stress and immunogenic cell death.

  2013cited by this paper
• Re-Directing an Alkylating Agent to Mitochondria Alters Drug Target and Cell Death Mechanism

  2013cited by this paper
• Combating apoptosis and multidrug resistant cancers by targeting lysosomes.

  2013cited by this paper
• DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology.

  2013cited by this paper
• Organelle targeting: third level of drug targeting

  2013cited by this paper
• Targeting nucleocytoplasmic transport in cancer therapy

  2013cited by this paper
• Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition.

  2013cited by this paper
• The lysosome: from waste bag to potential therapeutic target.

  2013cited by this paper
• Mitochondria and cancer

  2012cited by this paper
• Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes

  2012cited by this paper
• Deconvoluting the context-dependent role for autophagy in cancer

  2012cited by this paper
• A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

  2012cited by this paper
• Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.

  2012cited by this paper
• Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells.

  2012cited by this paper
• Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin.

  2011cited by this paper
• Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

  2011cited by this paper
• Selective labeling of the endoplasmic reticulum in live cells with silicon quantum dots.

  2011cited by this paper
• Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy.

  2011cited by this paper
• Endosomal escape pathways for delivery of biologicals.

  2011cited by this paper
• Nuclear drug delivery for cancer chemotherapy.

  2011cited by this paper
• Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.

  2010cited by this paper
• Subcellular targeting strategies for drug design and delivery

  2010cited by this paper
• Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity

  2010cited by this paper
• Targeting mitochondria for cancer therapy

  2010cited by this paper
• Activatable photosensitizers for imaging and therapy.

  2010cited by this paper
• Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.

  2010cited by this paper
• Immunogenic death of colon cancer cells treated with oxaliplatin

  2010cited by this paper
• Breaking down the barriers: siRNA delivery and endosome escape

  2010cited by this paper
• The pharmacokinetics of cell-penetrating peptides.

  2010cited by this paper
• Nuclear drug delivery to target tumour cells.

  2009cited by this paper
• Recent advances in the use of cell-penetrating peptides for medical and biological applications.

  2009cited by this paper
• Targeting the endoplasmic reticulum-stress response as an anticancer strategy.

  2009cited by this paper
• Lysosomal involvement in cell death and cancer.

  2009cited by this paper
• Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.

  2008cited by this paper
• Lysosomal membrane permeabilization in cell death

  2008cited by this paper
• Quantitative modeling of selective lysosomal targeting for drug design

  2008cited by this paper
• Gold nanoparticles in delivery applications.

  2008cited by this paper
• Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.

  2007cited by this paper
• Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy.

  2007cited by this paper
• Calreticulin exposure dictates the immunogenicity of cancer cell death

  2007cited by this paper
• Targeted pharmaceutical nanocarriers for cancer therapy and imaging

  2007cited by this paper
• Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine.

  2007cited by this paper
• Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.

  2007cited by this paper
• Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes.

  2007cited by this paper
• Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging.

  2007cited by this paper
• Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria.

  2007cited by this paper
• Shiga-like Toxin Subunit B (SLTB)-Enhanced Delivery of Chlorin e6 (Ce6) Improves Cell Killing

  2006cited by this paper
• Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.

  2006cited by this paper
• Photodynamic therapy and anti-tumour immunity

  2006cited by this paper
• Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

  2006cited by this paper
• Nuclear delivery of macromolecules: barriers and carriers.

  2005cited by this paper
• Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.

  2005cited by this paper
• Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

  2005cited by this paper
• Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications.

  2005cited by this paper
• Lysosomes as targets for cancer therapy.

  2005cited by this paper
• Multiple cell death pathways as regulators of tumour initiation and progression

  2004cited by this paper
• Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization

  2004cited by this paper
• Lysosomes in cell death

  2004cited by this paper
• Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin

  2004cited by this paper
• Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis.

  2004cited by this paper
• A review of selected anti‐tumour therapeutic agents and reasons for multidrug resistance occurrence

  2004cited by this paper
• Mechanisms of nuclear transport and interventions.

  2003cited by this paper
• Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.

  2003cited by this paper
• Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm.

  2003cited by this paper
• At the acidic edge: emerging functions for lysosomal membrane proteins.

  2003cited by this paper
• Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes.

  2003cited by this paper
• Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes

  2003cited by this paper
• Destination ‘Lysosome’: a target organelle for tumour cell killing?

  2003cited by this paper
• Four deaths and a funeral: from caspases to alternative mechanisms

  2001cited by this paper
• Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex.

  2001cited by this paper
• Nonviral gene therapy: promises and challenges

  2000cited by this paper
• Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

  2000cited by this paper

• Synthesis of copaiba (Copaifera officinalis) oil nanoemulsion and the potential against Zika virus: An in vitro study

  2023cites this paper
• Application of Nanomedicine in Immunotherapy: Recent Advances and Prospects

  2023cites this paper
• Pharmaceutical nanotechnology: Antimicrobial peptides as potential new drugs against WHO list of critical, high, and medium priority bacteria.

  2022cites this paper
• Andiroba oil and nanoemulsion (Carapa guianensis Aublet) reduce lesion severity caused by the antineoplastic agent doxorubicin in mice.

  2021cites this paper
• Potential Therapies and Diagnosis Based on Golgi-targeted Nano Drug Delivery Systems.

  2021cites this paper
• Nanotechnology and Immunoengineering: How nanotechnology can boost CAR-T therapy.

  2020cites this paper
• Photodynamic therapy mediated by aluminium-phthalocyanine nanoemulsion eliminates primary tumors and pulmonary metastases in a murine 4T1 breast adenocarcinoma model.

  2020cites this paper
• Nanomedicine beyond tumor passive targeting, what next?

  2020cites this paper
• Oily core/amphiphilic polymer shell nanocapsules change the intracellular fate of doxorubicin in breast cancer cells.

  2019cites this paper
• Molecular determinants as therapeutic targets in cancer chemotherapy: An update.

  2019cites this paper
• Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents.

  2019cites this paper
• Betulin-3,28-diphosphate as a Component of Combination Cytostatic Drugs for the Treatment of Ehrlich Ascites Carcinoma In Vitro and In Vivo Experiments

  2018cites this paper
• Nanocapsules for the co-delivery of selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro

  2017cites this paper